As American as Acid Reflux
Over the counter drug advertising is less regulated than prescription drug marketing, and selling directly to consumers comes with the benefit of bypassing an expert middleman: your doctor. But...
View ArticleMedical Journals Follow Docs to the iPad
It’s something of an enigma that most physicians are keen to learn about and use cutting edge medicines and devices for their patients, but are often apathetic or worse when it comes to new...
View ArticleAdvancing Pharma's Social Media Listening Analytics
Big Pharma’s tin ear for social, user-generated content online is softening despite regulatory anxiety. In the quest to better understand what patients and doctors need, pharma – thanks in part to a...
View ArticleWorking Out the Kinks in Health IT
Industry executives and government officials convened in Washington DC yesterday to examine the present state of health information technology (HIT), and to identify the bugs, challenges and hiccups...
View ArticleDiabetes Drug Launch 2012: Tip-tops and Promo-flops
With Halloween candy flooding the shelves in pharmacies across the nation, it’s only appropriate that we turn the conversation toward an ever-growing drug market and therapeutic area: diabetes....
View ArticleLocating the Human Ghost in the Digital Machine
Featured panelists at ExL’s annual Digital Pharma East conference this week included practicing physicians, vocal ePatients, social media gurus and digital marketing consultants with plenty of hours...
View ArticlePharmacists: The Other White Coats
Patients in search of face time with a healthcare provider are stopping into their local drugstores, where consultations are free and the wait time is shorter. Pharmacists are in a unique position,...
View ArticleHepatitis C: Engaging Patients Online
Given the amount of activity in the hepatitis C drug development space – as evidenced in PharmExec’s 2013 Pipeline report – patients are scouring the internet for information on the disease, available...
View ArticleWhy Don't Those Damn Marketers 'Do' Digital?
By Sven Awege. Over the last few years I’ve worked with pharma marketers trying to preach and teach the virtues of digital channels. It has been a thankless task, with bucket loads of blood, sweat, and...
View ArticleTom Abrams: Caronia Won't Stop Off-Label Enforcement
The much-discussed US v. Caronia case, which has raised questions about the Food and Drug Administration prosecution of pharma companies for making off-label product claims, doesn’t change very much,...
View ArticleePharma Summit: Turning Big Data into Better Content
Physicians and patients are more intimately engaged with their digital devices than ever before, but the content pharma delivers is either rigidly scientific or numbingly bland. Can stronger analytical...
View ArticleFollowing Industry, OPDP Hopes to Eliminate Silos in Ad Review
The Office of Prescription Drug Promotion (OPDP) is reorganizing its two primary advertising review divisions – professional and consumer – in an attempt to stay in line with the silo-breaking,...
View ArticleChanging the DNA of Pharma Patient Adherence Programs
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors. Pharma is also experiencing epigenetic change. Human genes are formed from...
View ArticleForget Digitial Differentiation: Focus on Cross-Channel 'Fusion'
Forget digital differentiation and innovation. You need to be focusing on cross-channel ‘fusion’, writes Peter Houston. Like you, I get invites to attend educational webinars on an almost daily basis;...
View ArticleWhy Social Media Won't Replace Pharma Meetings
It’s OK, social media won’t replace Pharma meetings I read a blog post recently where Brian S. McGowan PhD predicted 50 percent of medical meetings will be replaced by virtual courses within five...
View ArticleIs Pinterest the Risk-Free Social Channel for Pharma?
Spoiler Alert: the answer is no, writes Peter Houston. Peter Houston I recently came across a blog post headlining Pinterest as the “safest place” for medical marketers to start with social media. All...
View ArticleSocial Media's Not So Scary… Now for Social Business
Social media’s not so scary… now for social business I must be going soft. I actually caught myself feeling sorry for pharma marketers the other day. In a moment of weakness, which you’ll be glad to...
View ArticleCompliance and Reporting: The Case for a Single System
by James Pierce Pharmaceutical companies are awash in a sea of compliance regulations that affect their business operations both inside and outside the US. This August, one more compliance wave will...
View ArticleCMS taps IT firm CGI for Sunshine Act Data Dump
Shantanu Agrawal, director, data sharing & partnership group, Center for Program Integrity, CMS Speaking at CBI’s Sunshine & Aggregate Spend Conference in Washington DC on Tuesday, Shantanu...
View ArticlePromotional Review Committees: Shire Sets the Standard on Achieving High...
by Arthur Lazarus What does it take for internal Promotional Review Committees to function at their best and avoid costly mistakes to the company? A leading industry practitioner offers 15 tips for...
View Article
More Pages to Explore .....